Frost & Sullivan ranks RapidAI's enterprise platform ahead of 96% in the industry

Get report
Skip to content

Frost & Sullivan ranks RapidAI's enterprise platform ahead of 96% in the industry

Get report
  • There are no suggestions because the search field is empty.
Request a Demo
Request a Demo

Core Capabilities

Featured

Radar metrics
BLOG The market has changed: Frost & Sullivan's 2026 Radar shows who's leading it RapidAI Chief Business Officer David Stoffel, MD, MBA, breaks down what this recognition signals — and what it means for health systems planning their AI strategy for the years ahead LEARN MORE
Platform overview
Request a Demo

RADIOLOGY SUPPORT

Neurovascular

Cardiac + vascular

LIFE SCIENCES

Featured

Cognitive Burden index RapidAI 2025
BLOG Radiology’s real challenge Read about the reality of cognitive burden LEARN MORE
Request a Demo

BUILT TO SUPPORT THE FULL SYSTEM

FEATURED

Resource_1600x900_C-Suite-Exec Insights_white paper
WHITE PAPER Empowering healthcare leaders with a deep clinical AI enterprise platform Learn how AI can address real-world challenges for administrators LEARN MORE
Overview
Request a Demo

Core Capabilities

Featured

Radiology Rewired podcast
PODCAST Season 1 available now Exploring how AI is transforming Radiology—one conversation at a time with clinicians and innovators LEARN MORE
Overview
Request a Demo

TRAINING & LEARNING

HELP & ASSISTANCE

Overview
Request a Demo

LEARN MORE ABOUT RAPIDAI

WORK WITH US

FEATURED

video thumbnail for dr Gregory Albers
VIDEO The story behind RapidAI Hear our founder, Greg Albers, MD, tell the history of how the company came to be Watch now
Company overview
Request a Demo
Press Release

iSchemaView Introduces New Mobile and Notification Platform Features Across Its Family of Rapid Products

Messaging, Notification and Rapid Mobile App Enhancements to the RAPID Intelligent Services Platform Further Elevate the De Facto Standard Imaging Platform for Stroke Care

Share to

Messaging, Notification and Rapid Mobile App Enhancements to the RAPID Intelligent Services Platform Further Elevate the De Facto Standard Imaging Platform for Stroke Care

Menlo Park, Calif. and Danvers, Mass. — January 31, 2019 — iSchemaView, the worldwide leader in advanced imaging for stroke, today announced significant upgrades to the RAPID APP as well as other messaging and notification capabilities. In its latest release, the world’s most powerful and feature-rich neuroimaging software, RAPID, now includes additional customization of notifications for hospitals and physicians. It also incorporates support to customize the delivery of critical Personal Health Information (PHI) and of RAPID’s latest indication for thrombectomy. Developed by leading stroke experts, the RAPID Artificial Intelligence framework combines deep learning, machine learning and expert feature extraction. Together these provide unparalleled sensitivity and specificity across stroke modules (CT perfusion, MR diffusion and perfusion, CTA and CT ASPECT scoring). Results are then delivered by the RAPID Intelligence Services Platform via PACS, email, text, the RAPID APP or corporate partner workflow systems. “The latest updates to RAPID’s powerful mobile capabilities provide critical convenience and functionality for all of our users,” said Anil Singhal, MD, iSchemaView SVP Worldwide Operations. “The enhanced RAPID Intelligent Services Platform enables stroke specialists and their teams to communicate with a speed and accuracy that can improve outcomes for stroke patients in what is always a time-sensitive environment.” New mobile enhancements to the RAPID Intelligent Services Platform, include: Custom notifications for any RAPID module — RAPID CTA, RAPID ASPECTS, RAPID CTP and RAPID MRI Delivery of the right information to the right people at the right time with notifications customized by hospital, physician or by case New options for PHI, offering customized PHI content limits to accommodate local regulations, hospital policies or physician preferences Notification support of RAPID’s additional FDA clearance regarding thrombectomy — the new clearance notes that RAPID CT-Perfusion and RAPID MR-Perfusion can be used by physicians to aid in the selection of acute stroke patients with known occlusion of the internal carotid artery or proximal middle cerebral artery for a clot removal procedure; RAPID is the only imaging platform approved for selecting stroke patients for clot removal Updated release of the RAPID APP on both Apple iOS and Android platforms The latest release of RAPID empowers hospitals and stroke centers to set custom email, text or in-app notifications for physicians and clinical team members based on clinical thresholds across modules. RAPID also integrates with third-party communication and messaging applications designed for the hospital environment. In addition, users of the RAPID APP can view raw Non-Contrast CT images and CTA source data. These enhancements to the RAPID Intelligent Services Platform improve the speed with which time-critical RAPID brain scans and results reach members of an acute stroke care team. This accelerates key diagnostic decision making for the patient and facilitates the care team’s communication.

Contact PR

Jessica Stebing

Jessica Stebing

Group Manager, Marketing Communications

stebing@rapidai.com